Michael C. Welsh
Präsident bei Almasa Capital, Inc.
Profil
Michael C.
Welsh is currently the President of Almasa Capital, Inc. He was previously the Chairman of Micralyne, Inc. and held director positions at Biomira, Inc. and Cascadian Therapeutics LLC.
He was also a partner at Welsh & Co. Mr. Welsh received an undergraduate degree from the University of Alberta.
Aktive Positionen von Michael C. Welsh
| Unternehmen | Position | Beginn |
|---|---|---|
| Almasa Capital, Inc. | Präsident | - |
Ehemalige bekannte Positionen von Michael C. Welsh
| Unternehmen | Position | Ende |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Direktor/Vorstandsmitglied | 11.12.2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Direktor/Vorstandsmitglied | 11.12.2007 |
| Welsh & Co. | Corporate Officer/Principal | - |
Micralyne, Inc.
 Micralyne, Inc. Industrial MachineryProducer Manufacturing Micralyne, Inc. develops and manufactures micro fabricated products. It offers wafer level packaging, die level packaging, silicon optical bench and spatial light valve. The firm’s services are used in the areas of microfluidics and MEMs sensors. The company was founded in 1982 and is headquartered in Edmonton, Canada. | Vorsitzender | - |
Ausbildung von Michael C. Welsh
| University of Alberta | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
Micralyne, Inc.
Micralyne, Inc. Industrial MachineryProducer Manufacturing Micralyne, Inc. develops and manufactures micro fabricated products. It offers wafer level packaging, die level packaging, silicon optical bench and spatial light valve. The firm’s services are used in the areas of microfluidics and MEMs sensors. The company was founded in 1982 and is headquartered in Edmonton, Canada. | Producer Manufacturing |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
| Welsh & Co. | |
| Almasa Capital, Inc. |
